全文获取类型
收费全文 | 2015篇 |
免费 | 85篇 |
国内免费 | 66篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 93篇 |
妇产科学 | 20篇 |
基础医学 | 138篇 |
口腔科学 | 125篇 |
临床医学 | 234篇 |
内科学 | 493篇 |
皮肤病学 | 46篇 |
神经病学 | 109篇 |
特种医学 | 305篇 |
外科学 | 120篇 |
综合类 | 32篇 |
预防医学 | 82篇 |
眼科学 | 70篇 |
药学 | 201篇 |
中国医学 | 1篇 |
肿瘤学 | 61篇 |
出版年
2022年 | 8篇 |
2021年 | 22篇 |
2020年 | 15篇 |
2019年 | 23篇 |
2018年 | 26篇 |
2017年 | 25篇 |
2016年 | 27篇 |
2015年 | 29篇 |
2014年 | 40篇 |
2013年 | 69篇 |
2012年 | 67篇 |
2011年 | 61篇 |
2010年 | 61篇 |
2009年 | 75篇 |
2008年 | 85篇 |
2007年 | 114篇 |
2006年 | 65篇 |
2005年 | 75篇 |
2004年 | 56篇 |
2003年 | 51篇 |
2002年 | 40篇 |
2001年 | 42篇 |
2000年 | 39篇 |
1999年 | 40篇 |
1998年 | 72篇 |
1997年 | 78篇 |
1996年 | 83篇 |
1995年 | 71篇 |
1994年 | 56篇 |
1993年 | 60篇 |
1992年 | 33篇 |
1991年 | 47篇 |
1990年 | 47篇 |
1989年 | 58篇 |
1988年 | 40篇 |
1987年 | 51篇 |
1986年 | 30篇 |
1985年 | 33篇 |
1984年 | 24篇 |
1983年 | 30篇 |
1982年 | 22篇 |
1981年 | 21篇 |
1980年 | 27篇 |
1979年 | 12篇 |
1978年 | 7篇 |
1977年 | 12篇 |
1976年 | 7篇 |
1975年 | 11篇 |
1972年 | 16篇 |
1969年 | 6篇 |
排序方式: 共有2166条查询结果,搜索用时 31 毫秒
1.
2.
Facial reanimation after acoustic neuroma excision is currently accomplished using a variety of surgical techniques. A multi-institutional survey of patient perceptions of facial reanimation success was accomplished by mailing a questionnaire to 809 randomly selected members of the Acoustic Neuroma Association. Four hundred sixty patients who underwent 296 reanimation procedures responded. Facial to hypoglossal nerve anastomosis, tarsorrhaphy, and upper eyelid implants were most frequently performed. The patient's estimations of initial deficit, spontaneous recovery, and overall satisfaction with the reanimation procedures are discussed. 相似文献
3.
Acoustic neuroma--the patient's perspective: subjective assessment of symptoms, diagnosis, therapy, and outcome in 541 patients 总被引:4,自引:0,他引:4
Surgical treatment of acoustic neuroma has been reviewed in the medical literature, but assessment of outcome from the patient's perspective has received little attention. The Acoustic Neuroma Association (A.N.A.) is a large organization of acoustic neuroma patients which provides information and support services. This article reports the subjective assessment of symptoms, diagnosis, treatment, and outcome as evaluated by 541 A.N.A. members. This retrospective study presents an extensive overview of the experience of acoustic neuroma patients treated at a variety of institutions, and provides a unique perspective not previously represented in the medical literature. 相似文献
4.
Leonidas JC; Berdon WE; Valderrama E; Neveling U; Schuval S; Weiss SJ; Hilfer C; Godine L 《Radiology》1996,198(2):377
5.
6.
M. Wiegand A. A. Möller C. J. Lauer S. Stolz W. Schreiber M. Dose J. C. Krieg 《Journal of neurology》1991,238(4):203-208
Summary Nocturnal sleep was studied in 16 inpatients with Huntington's disease. In comparison with healthy controls, patients exhibited a disturbed sleep pattern with increased sleep onset latency, reduced sleep efficiency, frequent nocturnal awakenings, more time spent awake and less slow wave sleep. These abnormalities correlated in part with duration of illness, severity of clinical symptoms, and degree of atrophy of the caudate nucleus. Patients showed an increased density of sleep spindles. 相似文献
7.
8.
9.
B.E. Jones C.B. Boylan M. Fritsche M. Juhasz C. Jackson S.J. Wiegand C. Hyman R.M. Lindsay C.A. Altar 《Brain research》1996,709(2):275
Rat models of Parkinson's disease typically employ a rapid nigral injection of 6-hydroxydopamine (6-OHDA) to produce a near-complete loss of nigrostriatal dopamine neurons, and thus model end stage disease. The present report describes the use of a continuous, low dose infusion of 6-OHDA into the striatum which produces a terminal axotomy of nigrostriatal dopamine neurons and protracted behavioral response. A solution of 6-OHDA in 0.4% ascorbate, delivered at 37°C from osmotic minipumps, was stable for 8 days as determined by its retained toxicity to a dopaminergic neuroblastoma cell line. The continuous infusion of 0.2 μg 6-OHDA per h did not affect the striatal uptake of [3H]GABA, [3H]choline, or [3H]glutamate but reduced [3H]dopamine uptake by 55% within 1.5 days after the start of the infusion. The striatal infusion of 6-OHDA produced a dose-dependent reduction of striatal dopamine and DOPAC levels but did not alter HVA, 5-HT, or 5-HIAA. An increase in amphetamine-induced ipsiversive rotations occurred within 1.5 days after the acute striatal injection of 20 μg or 30 μg of 6-OHDA but required 4 days to develop with the continuous 6-OHDA infusion. The topography of the lesion mapped by [3H]mazindol binding showed that, begining by 1.5 days, a diffuse depletion of terminals encompassed much of the striatum in the 30 μg acute injection group, whereas in the continuously infused rats, the lesion was apparent only by 4 days and was restricted to a smaller and more completely lesioned area. Unlike acutely lesioned animals, continuously infused rats revealed no obvious loss of dopamine neurons in the pars compacta by 5 weeks after 6-OHDA. The continuous striatal infusion of 6-OHDA can produce a topographically limited terminal axotomy of dopamine neurons and a protracted behavioral impairment. 相似文献
10.
Kaufmann SJ; Sharif K; Sharma V; McVerry BA 《Human reproduction (Oxford, England)》1998,13(2):498-499
The patient was diagnosed in childhood as having severe congenital
neutropenia and had recurrent admissions with severe infections. In 1987,
prior to getting married, she was sterilized. She continued to require i.v.
antibiotics when she contracted a severe infection. On one occasion, she
was treated with growth colony stimulating factor (G- CSF). Her increased
neutrophil count was sustained following this treatment. In June 1993, she
wished to start a family and underwent in- vitro fertilization (IVF)
treatment. G-CSF was given prior to oocyte retrieval. She conceived on her
first cycle and an ultrasound scan revealed a singleton pregnancy.
Throughout the course of the pregnancy, her white cell count was monitored
closely and remained at <1.0x10(9)/l. The pregnancy progressed
uneventfully and at 37 weeks gestation she was admitted for G-CSF
injections. At 38 weeks she was delivered of a boy weighing 3350 g, by
elective Caesarean section. His white cell count was normal. This is the
first case of G-CSF being used before conception and during pregnancy in a
patient with congenital neutropenia. It shows that advances in cytokine
therapy and close interdisciplinary liaison can lead to a successful
outcome and help patients, who would otherwise remain childless, to achieve
a family.
相似文献